Immediate Impact
50 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of I. Meek being referenced
Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial
2016
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| I. Meek | 158 | 20 | 34 | 96 | 53 | 16 | 410 | |
| Anil Pareek | 96 | 9 | 26 | 104 | 47 | 28 | 415 | |
| Christopher J. Needs | 61 | 4 | 15 | 96 | 52 | 12 | 411 | |
| Stephen D. Sholkoff | 84 | 9 | 14 | 152 | 86 | 12 | 420 | |
| Mirjana Veselinović | 172 | 10 | 24 | 25 | 14 | 23 | 440 | |
| Shivani Jaswal | 68 | 41 | 24 | 29 | 22 | 32 | 342 | |
| D. Graham | 82 | 2 | 17 | 208 | 37 | 16 | 380 | |
| U Armani | 92 | 4 | 30 | 15 | 50 | 22 | 350 | |
| Hoi Y. Tong | 56 | 9 | 31 | 117 | 26 | 26 | 371 | |
| Michèle Bally | 75 | 12 | 13 | 167 | 77 | 8 | 400 | |
| Edward A. Hartshorn | 28 | 35 | 62 | 69 | 21 | 28 | 355 |
All Works
Login with ORCID to disown or claim papers
Loading papers...